Assessment of the procedural success of Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with chronic total occlusion lesions.
Phase of Trial: Phase II
Latest Information Update: 10 Sep 2015
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- 10 Sep 2015 New trial record